Table 1.
Number of AKT1 E17K mutated cases in various cancers
| Cancer Types | Number of AKT1 E17K Mutated Cases | Total Cases | Percentage of Mutated Cases (%) |
|---|---|---|---|
| Breast invasive carcinoma (BRCA) | 25 | 987 | 2.53% |
| Uterine Corpus Endometrial Carcinoma (UCEC) | 9 | 530 | 1.70% |
| Colon adenocarcinoma (COAD) | 4 | 400 | 1.00% |
| Cervical and endocervical cancers (CESC) | 3 | 289 | 1.04% |
| Thyroid carcinoma (THCA) | 3 | 492 | 0.61% |
| Lung adenocarcinoma (LUAD) | 2 | 1063 | 0.19% |
| Prostate adenocarcinoma (PRAD) | 2 | 498 | 0.40% |
| Skin Cutaneous Melanoma (SKCM) | 2 | 469 | 0.43% |
| Bladder urothelial carcinoma (BLCA) | 1 | 412 | 0.24% |
| Head and Neck squamous cell carcinoma (HNSC) | 1 | 508 | 0.20% |
| Stomach adenocarcinoma (STAD) | 1 | 440 | 0.23% |
| Total | 53 | 6088 | 0.87% |
| Average | 5 | 609 | 0.82% |